本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Syndax Pharmaceuticals, Inc.

13.70
+0.28002.09%
盘后13.700.00000.00%16:27 EDT
成交量:165.89万
成交额:2,268.54万
市值:11.79亿
市盈率:-3.68
高:13.98
开:13.45
低:13.25
收:13.42
数据加载中...
2021/05/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/08

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report
2021/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/09

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/02

重要事件披露

8-K - Current report